126 related articles for article (PubMed ID: 34572906)
1. High Cell-Free DNA Integrity Is Associated with Poor Breast Cancer Survival.
Lamminaho M; Kujala J; Peltonen H; Tengström M; Kosma VM; Mannermaa A
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572906
[TBL] [Abstract][Full Text] [Related]
2. Circulating free DNA integrity and concentration as independent prognostic markers in metastatic breast cancer.
Cheng J; Holland-Letz T; Wallwiener M; Surowy H; Cuk K; Schott S; Trumpp A; Pantel K; Sohn C; Schneeweiss A; Burwinkel B
Breast Cancer Res Treat; 2018 May; 169(1):69-82. PubMed ID: 29340881
[TBL] [Abstract][Full Text] [Related]
3. Plasma DNA integrity as a biomarker for primary and metastatic breast cancer and potential marker for early diagnosis.
Madhavan D; Wallwiener M; Bents K; Zucknick M; Nees J; Schott S; Cuk K; Riethdorf S; Trumpp A; Pantel K; Sohn C; Schneeweiss A; Surowy H; Burwinkel B
Breast Cancer Res Treat; 2014 Jul; 146(1):163-74. PubMed ID: 24838941
[TBL] [Abstract][Full Text] [Related]
4. Plasma Cell-Free DNA Integrity Assessed by Automated Electrophoresis Predicts the Achievement of Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Breast Cancer.
Cirmena G; Ferrando L; Ravera F; Garuti A; Dameri M; Gallo M; Barbero V; Ferrando F; Del Mastro L; Garlaschi A; Friedman D; Fregatti P; Ballestrero A; Zoppoli G
JCO Precis Oncol; 2022 Feb; 6():e2100198. PubMed ID: 35201850
[TBL] [Abstract][Full Text] [Related]
5. Plasma cell-free DNA integrity: a potential biomarker to monitor the response of breast cancer to neoadjuvant chemotherapy.
Wang W; Zhang W; Su L; Sang J; Wang S; Yao Y
Transl Cancer Res; 2019 Aug; 8(4):1531-1539. PubMed ID: 35116896
[TBL] [Abstract][Full Text] [Related]
6. Plasma cell-free DNA integrity plus circulating tumor cells: a potential biomarker of no distant metastasis breast cancer.
Wang W; Liang M; Ma G; Li L; Zhou W; Xia T; Xie H; Wang S
Neoplasma; 2017; 64(4):611-618. PubMed ID: 28485169
[TBL] [Abstract][Full Text] [Related]
7. Alter circulating cell-free DNA variables in plasma of ovarian cancer patients.
Yu Z; Qin S; Wang H
J Obstet Gynaecol Res; 2019 Nov; 45(11):2237-2242. PubMed ID: 31502389
[TBL] [Abstract][Full Text] [Related]
8. Cell-free circulating DNA integrity is an independent predictor of impending breast cancer recurrence.
Cheng J; Cuk K; Heil J; Golatta M; Schott S; Sohn C; Schneeweiss A; Burwinkel B; Surowy H
Oncotarget; 2017 Aug; 8(33):54537-54547. PubMed ID: 28903362
[TBL] [Abstract][Full Text] [Related]
9. Circulating cell-free DNA variables as marker of ovarian cancer patients: A pilot study.
Stamenkovic S; Cheng J; Surowy H; Burwinkel B; Gündert M
Cancer Biomark; 2020; 28(2):159-167. PubMed ID: 32176629
[TBL] [Abstract][Full Text] [Related]
10. The prognostic value of circulating cell-free DNA in breast cancer: A meta-analysis.
Tan G; Chu C; Gui X; Li J; Chen Q
Medicine (Baltimore); 2018 Mar; 97(13):e0197. PubMed ID: 29595655
[TBL] [Abstract][Full Text] [Related]
11. Limited Utility of Circulating Cell-Free DNA Integrity as a Diagnostic Tool for Differentiating Between Malignant and Benign Thyroid Nodules With Indeterminate Cytology (Bethesda Category III).
Thakur S; Tobey A; Daley B; Auh S; Walter M; Patel D; Nilubol N; Kebebew E; Patel A; Jensen K; Vasko V; Klubo-Gwiezdzinska J
Front Oncol; 2019; 9():905. PubMed ID: 31620364
[No Abstract] [Full Text] [Related]
12. Cell-Free Circulating DNA Integrity Based on Peripheral Blood as a Biomarker for Diagnosis of Cancer: A Systematic Review.
Cheng J; Tang Q; Cao X; Burwinkel B
Cancer Epidemiol Biomarkers Prev; 2017 Nov; 26(11):1595-1602. PubMed ID: 28830871
[No Abstract] [Full Text] [Related]
13. Diagnostic Role of Cell-free DNA Integrity in Thyroid Cancer Particularly for Bethesda IV Cytology.
Higazi AM; El Hini SH; El-Sharkawy EA; Gayyed MF; Aziz NA; Matta RA
Endocr Pract; 2021 Jul; 27(7):673-681. PubMed ID: 33601025
[TBL] [Abstract][Full Text] [Related]
14. Plasma ALU-247, ALU-115, and cfDNA Integrity as Diagnostic and Prognostic Biomarkers for Breast Cancer.
Hussein NA; Mohamed SN; Ahmed MA
Appl Biochem Biotechnol; 2019 Mar; 187(3):1028-1045. PubMed ID: 30151636
[TBL] [Abstract][Full Text] [Related]
15. High mutation burden of circulating cell-free DNA in early-stage breast cancer patients is associated with a poor relapse-free survival.
Kujala J; Hartikainen JM; Tengström M; Sironen R; Kosma VM; Mannermaa A
Cancer Med; 2020 Aug; 9(16):5922-5931. PubMed ID: 32602248
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology.
Griguolo G; Pouderoux S; Dieci MV; Jacot W; Bourgier C; Miglietta F; Firmin N; Conte P; Viala M; Guarneri V; Darlix A
Oncologist; 2018 Nov; 23(11):1289-1299. PubMed ID: 30120164
[TBL] [Abstract][Full Text] [Related]
17. Circulating cell-free DNA as a prognostic and predictive biomarker in non-small cell lung cancer.
Ai B; Liu H; Huang Y; Peng P
Oncotarget; 2016 Jul; 7(28):44583-44595. PubMed ID: 27323821
[TBL] [Abstract][Full Text] [Related]
18. Combining
Woff E; Kehagias P; Vandeputte C; Ameye L; Guiot T; Paesmans M; Hendlisz A; Flamen P
J Nucl Med; 2019 Oct; 60(10):1366-1372. PubMed ID: 30850494
[TBL] [Abstract][Full Text] [Related]
19. Local Surgery Improves Survival in Patients with Primary Metastatic Breast Cancer: A Population-Based Study.
Zhao YY; Sun HF; Yang XL; Zhao Y; Chen MT; Jin W
Breast Care (Basel); 2020 Aug; 15(4):392-399. PubMed ID: 32982650
[TBL] [Abstract][Full Text] [Related]
20. Association of EGFR L858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial.
Karachaliou N; Mayo-de las Casas C; Queralt C; de Aguirre I; Melloni B; Cardenal F; Garcia-Gomez R; Massuti B; Sánchez JM; Porta R; Ponce-Aix S; Moran T; Carcereny E; Felip E; Bover I; Insa A; Reguart N; Isla D; Vergnenegre A; de Marinis F; Gervais R; Corre R; Paz-Ares L; Morales-Espinosa D; Viteri S; Drozdowskyj A; Jordana-Ariza N; Ramirez-Serrano JL; Molina-Vila MA; Rosell R;
JAMA Oncol; 2015 May; 1(2):149-57. PubMed ID: 26181014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
